Want to see HK:8513 full AI Analyst Report?
Top Page
IAG Holdings Limited
(8513)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$0.37
▲(205.83% Upside)
Action:Upgraded
Date:09/06/26
The score is primarily driven by improving fundamentals (revenue growth, margin recovery, and strong TTM operating/free cash flow). This is tempered by still-negative profitability and elevated leverage (high debt-to-equity), which increases financial risk. Technically, near-term momentum is positive, but the stock remains below longer-term moving averages, limiting the overall rating.
Positive Factors
Revenue Rebound
The sharp revenue recovery indicates improving demand and renewed commercial traction after earlier declines. Sustained top-line growth would provide operating leverage and a stronger base for completing the company’s broader turnaround.
Negative Factors
Persistent Net Losses
Despite stronger revenue and EBITDA, the company has not yet achieved durable bottom-line profitability. Multi-year net losses constrain retained capital, weaken financial flexibility, and leave the turnaround dependent on further margin improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
The sharp revenue recovery indicates improving demand and renewed commercial traction after earlier declines. Sustained top-line growth would provide operating leverage and a stronger base for completing the company’s broader turnaround.
Read all positive factors
IAG Holdings Limited (8513) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$29.87M
Dividend YieldN/A
Average Volume (3M)8.13K
Price to Earnings (P/E)―
Beta (1Y)-0.57
Revenue Growth84.45%
EPS Growth66.40%
CountryHK
Employees94
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding81,845,535
10 Day Avg. Volume13,740
30 Day Avg. Volume8,133
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)10.20
Price to Sales (P/S)0.84
P/FCF Ratio64.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IAG Holdings Limited Business Overview & Revenue Model
Company Description
IAG Holdings Limited functions as an investment holding company, primarily focusing on the manufacturing and sale of injection-molded plastic components for single-use medical devices. The company also provides specialized tooling services, involv...
IAG Holdings Limited Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
38
Negative
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.55M | 18.59M | 10.46M | 9.15M | 13.90M | 19.77M |
| Gross Profit | 3.12M | 3.08M | 44.00K | -730.00K | 938.00K | 3.97M |
| EBITDA | 717.75K | 598.00K | -1.35M | -2.40M | -1.76M | -4.63M |
| Net Income | -406.00K | -612.00K | -2.63M | -6.75M | -3.06M | -7.05M |
Balance Sheet | ||||||
| Total Assets | 13.44M | 8.92M | 8.75M | 10.06M | 16.32M | 20.91M |
| Cash, Cash Equivalents and Short-Term Investments | 2.03M | 1.19M | 1.78M | 1.60M | 3.66M | 5.99M |
| Total Debt | 4.22M | 2.69M | 4.20M | 4.24M | 2.59M | 3.52M |
| Total Liabilities | 11.90M | 7.41M | 6.63M | 7.19M | 7.19M | 10.16M |
| Stockholders Equity | 1.56M | 1.52M | 2.14M | 2.88M | 8.65M | 10.10M |
Cash Flow | ||||||
| Free Cash Flow | 3.61M | 240.52K | -1.24M | -1.25M | -1.37M | 2.92M |
| Operating Cash Flow | 3.73M | 326.29K | -986.00K | -1.19M | -582.00K | 3.16M |
| Investing Cash Flow | -117.41K | -85.76K | -145.00K | 3.00K | -751.00K | -365.00K |
| Financing Cash Flow | -1.72M | -821.13K | 1.31M | 509.00K | -474.00K | -3.19M |
IAG Holdings Limited Technical Analysis
Positive
0.12
Price Trends
0.35
Positive
0.40
Negative
0.65
Negative
Market Momentum
<0.01
Negative
61.99
Neutral
67.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8513, the sentiment is Positive. The current price of 0.12 is below the 20-day moving average (MA) of 0.33, below the 50-day MA of 0.35, and below the 200-day MA of 0.65, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.99 is Neutral, neither overbought nor oversold. The STOCH value of 67.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8513.
IAG Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$29.87M | -11.96 | -26.34% | ― | 84.45% | 66.40% | |
49 Neutral | HK$48.40M | 1,180.00 | 0.90% | 7.69% | 6.13% | ― | |
48 Neutral | HK$64.62M | 4.26 | 12.17% | ― | 36.68% | ― | |
43 Neutral | HK$19.55M | -6.03 | -32.49% | ― | -21.61% | -140.20% |
* Healthcare Sector Average
HK:8513
IAG Holdings Limited
0.37
-0.83
-69.56%
HK:1889
Sanai Health Industry Group Company Limited
0.17
-0.28
-61.56%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.12
<0.01
1.75%
HK:6108
New Ray Medicine International Holding Ltd.
0.24
-0.15
-37.44%
HK:8161
MediNet Group Ltd.
0.47
-0.22
-31.88%
HK:8307
Medicskin Holdings Ltd.
0.12
-0.10
-44.75%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.